Search Results
Jan 29, 2026, 07:00 ET Hope Rising in Hainan: International NUT Carcinoma Center Launches in Boao
strategically focuses on oncology, immunology, and neurodegenerative diseases. It currently has multiple drug candidates advancing through Phase I, II, and III clinical trials.NHWD-870 is the world's first and only BET inhibitor targeting advanced NUT carcinoma. Having completed Phase II clinical trials,
More news about: Zhejiang Wenda Pharma Technology Co., Ltd.
Jan 29, 2026, 07:00 ET International Paper to Create Two Independent Public Companies and Reports Full-Year and Fourth Quarter 2025 Results
creation, target run rates and other expectations with respect to the combined company, including in light of our increased scale and global presence; (iii) risks associated with strategic business decisions including facility closures, business exits, operational changes, and portfolio rationalizations
More news about: International Paper
Jan 29, 2026, 06:31 ET Cat Financial Reports Fourth-Quarter and Full-Year 2025 Results
resulting increases to our cost of borrowing and adverse effects on our cost of funds, liquidity, competitive position and access to capital markets; (iii) changes in interest rates, currency fluctuations or market liquidity conditions; (iv) an increase in delinquencies, repossessions or net losses of our
More news about: Cat Financial
Jan 29, 2026, 06:30 ET ROYAL CARIBBEAN GROUP REPORTS 2025 RESULTS, ISSUES 2026 GUIDANCE
on a comparative basis. For the periods presented, these items included (i) other income; (ii) restructuring charges and other initiative expenses; (iii) equity investment impairment, recovery of losses, and other; and (iv) impairment losses.Adjusted EBITDA Margin is a non-GAAP measure that
More news about: Royal Caribbean Group
Jan 29, 2026, 06:30 ET Caterpillar Reports Fourth-Quarter and Full-Year 2025 Results
to end users is demonstrated by the company's Rolling 3 Month Retail Sales Statistics filed in a Form 8-K on Thursday, Jan. 29, 2026.iii. Information on non-GAAP financial measures is included in the appendix on pages 13 to 15.iv. Some amounts within this
More news about: Caterpillar Inc.
Jan 29, 2026, 06:30 ET Lazard Reports Fourth Quarter and Full Year 2025 Results
CVC Capital Partners on multiple engagements, Odyssey Investment Partners on a continuation fund, and advising on the closing of EIR Partner's Fund III. In addition, capital structure and debt raising assignments include Lighthouse, NeXtwind, and Ørsted.Lazard's preeminent restructuring and liability
More news about: Lazard
Jan 29, 2026, 06:00 ET Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne
favorable safety and tolerability in a Phase III open-label study- The exceptional efficacy of denifanstat (ASC40) observed in the Company's previously reported placebo-controlled Phase III trial coupled with a favorable safety profile in two Phase III trials provide a potential major break-through
More news about: Ascletis Pharma Inc.
Jan 29, 2026, 06:00 ET 歌禮宣佈同類首創每日一次口服FASN抑制劑地尼法司他（ASC40）治療痤瘡的III期開放標籤研究取得積極頂線結果
View original content:https://www.prnewswire.com/apac/zh/news-releases/fasnasc40iii-302673859.htmlSOURCE 歌禮製藥有限公司
More news about: 歌禮製藥有限公司
Jan 29, 2026, 06:00 ET PEA Report Confirms World Leading Alumina Resource in Saskatchewan
Estimates may have to be re-estimated based on, among other things: (i) fluctuations in mineral prices; (ii) results of drilling, and development; (iii) results of future test mining and other testing; (iv) metallurgical testing and other studies; (v) results of geological and structural modeling including
More news about: Canadian Energy Metals
Jan 29, 2026, 04:25 ET Inicio del ensayo ReDS-SAFE HF II
ReDS-SAFE HF II, un gran estudio multicéntrico, aleatorizado y controlado, promovido por los investigadores y financiado por el Instituto de Salud Carlos III y la Sociedad Española de Cardiología, ha comenzado oficialmente. El ensayo está diseñado para evaluar con mayor profundidad la eficacia y seguridad
More news about: Sensible Medical
Jan 29, 2026, 03:00 ET Cisco Expands European Renewable Energy Through Partnership with R.Power S.A. in Poland Facilitated by SR Inc's NZCB
The agreement supports the development of four new solar projects located in Poland: Wydartowo, Bieżyce, Ostrzeniewo III, and Nowy Zagór III, with a total contracted volume of 470 GWh. DLA Piper provided legal support for the agreement and SR Inc partner LevelTen Energy
More news about: SUSTAINABILITY ROUNDTABLE, INC.
Jan 29, 2026, 03:00 ET Cisco Expands European Renewable Energy Through Partnership with R.Power S.A. in Poland Facilitated by SR Inc's NZCB
The agreement supports the development of four new solar projects located in Poland: Wydartowo, Bieżyce, Ostrzeniewo III, and Nowy Zagór III, with a total contracted volume of 470 GWh. DLA Piper provided legal support for the agreement and SR Inc partner LevelTen Energy
More news about: SUSTAINABILITY ROUNDTABLE, INC.
Jan 29, 2026, 02:15 ET INVESTOR ALERT: CoreWeave, Inc. (CRWV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; and (iii) the foregoing was reasonably likely to have a material negative impact on CoreWeave's revenue.The CoreWeave class action lawsuit alleges
More news about: Robbins Geller Rudman & Dowd LLP
Jan 28, 2026, 21:39 ET WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
development and manufacturing solutions. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing.WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously
More news about: WuXi Biologics
Jan 28, 2026, 21:21 ET QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
antitumor activity as first-line therapy for CLDN18.2-positive/HER2-negative advanced GC/GEJ, supporting a phase III trial with Q-1802 10 mg/kg as recommended dose.Q-1802 phase III trial has recently been approved by Chinese CDE.About Q-1802 Q-1802, a humanized Claudin18.2/PD-L1
More news about: QureBio Ltd.
Jan 28, 2026, 18:23 ET ELS Reports Fourth Quarter Results
are not limited to the following: (i) the mix of site usage within the portfolio; (ii) yield management on our short-term resort and marina sites; (iii) scheduled or implemented rate increases on community, resort and marina sites; (iv) scheduled or implemented rate increases in annual payments under
More news about: Equity Lifestyle Properties, Inc.
Jan 28, 2026, 17:25 ET INVESTOR DEADLINE NEXT WEEK: Blue Owl Capital Inc. Investors with Substantial Losses Have Opportunity to Lead the Blue Owl Class Action Lawsuit
pressure on its asset base from business development company ("BDC") redemptions; (ii) as a result, Blue Owl was facing undisclosed liquidity issues; and (iii) consequently, Blue Owl would be likely to limit or halt redemptions of certain BDCs.The Blue Owl class action lawsuit further alleges
More news about: Robbins Geller Rudman & Dowd LLP
Jan 28, 2026, 16:38 ET Shrub Oak International School Unveils Renovated Student Hub Designed to Support Connection, Movement, and Regulation
support.Shrub Oak International School is accredited by:The National Independent Private Schools Association (NIPSA), Level III Therapeutic Certification, Academic Accreditation, with an Autism Endorsement;The Middle States Association Commission on Elementary and Secondary
More news about: Shrub Oak International School
Jan 28, 2026, 16:28 ET SOUTHWEST AIRLINES REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS; EXPECTS STRONG 2026 FINANCIAL PERFORMANCE FROM BUSINESS TRANSFORMATION
and growth in business and leisure segments, the Company's business transformation, Customer-focused product offering, and operational excellence; (iii) the Company's expectations with respect to providing future, range-bound guidance; (iv) the Company's capacity plans and expectations; (v) the Company's
More news about: Southwest Airlines Co.
Jan 28, 2026, 16:15 ET Brookdale Announces Preliminary Full Year 2025 Results and Introduces Full Year 2026 Annual Guidance
as part of the Company's underlying core operating performance and that management believes impact the comparability of performance between periods; (iii) the Company believes that this measure is used by research analysts and investors to evaluate the Company's operating results and to value companies
More news about: Brookdale Senior Living Inc.
Jan 28, 2026, 16:15 ET VIAVI Announces Second Quarter Fiscal 2026 Results
equipment and intangibles, (ii) charges such as severance, benefits and outplacement costs related to restructuring plans with a specific and defined term, (iii) costs for facilities not required for ongoing operations, and costs related to the relocation of certain equipment from these facilities and/or contract
More news about: VIAVI Financials
Jan 28, 2026, 16:15 ET First Financial Bancorp Announces Record Fourth Quarter, Full Year 2025 Financial Results and Quarterly Dividend
our future operating or financial performance, including revenues, income or loss and earnings or loss per share, (ii) future common stock dividends, (iii) our capital structure, including future capital levels, (iv) our plans, objectives and strategies, and (v) the assumptions that underlie our forward-looking
More news about: First Financial Bancorp.
Jan 28, 2026, 16:05 ET Century Communities Reports Fourth Quarter and Full Year 2025 Results
from period to period. The Company defines adjusted net income as consolidated net income before (i) income tax expense; (ii) inventory impairment; (iii) abandonment of lot option contracts; (iv) restructuring costs; (v) loss on debt extinguishment; (vi) impairment on other investment; and (vii) purchase
More news about: Century Communities, Inc.
Jan 28, 2026, 16:05 ET Washington Trust Reports Strong Fourth Quarter and Full-Year 2025 Results
and increases in wealth management and mortgage banking revenues," said Washington Trust Chairman and Chief Executive Officer Edward O. "Ned" Handy III. "As we enter 2026, the addition of resources in our commercial and wealth management business lines, including the recently announced dedicated institutional
More news about: Washington Trust Bancorp, Inc.
Jan 28, 2026, 16:05 ET CPKC showcases strength of Precision Scheduled Railroading; delivers record margins
customers or foreign railroads and excludes the time and distance travelled by: i) trains used in or around CPKC's yards; ii) passenger trains; and iii) trains used for repairing track. An increase in average train speed indicates improved on-time performance resulting in improved asset utilization.
More news about: CPKC